Abdelmoula MS, M’Hamdi Z, Amri F, Tebib N, Ben Turkia F, Ben Dridi MF, 2003. La leishmaniose viscérale chez l’enfant: facteurs pronostiques. Tunis Med 81 :535–539.
Bouratbine A, Aoun K, Chahed MD, Ben Ismail R, 1998. Données épidémiologiques sur la leishmaniose viscérale infantile en Tunisie en 1993. Med Mal Infect 28 :446–447.
Aoun K, Bouratbine A, 2008. Leishmaniasis. Rakel ER, Bope ET, eds. Conn’s Current Therapy 2008. Philadelphia: Saunders Elsevier, 94–98.
Mary C, Farault F, Lascombe L, Dumon H, 2004. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol 42 :5249–5255.
Antinori S, Calattini S, Piolini R, Longhi E, Bestetti G, Cacsio A, Parravicini C, Gorbellini M, 2009. Is real-time PCR more useful than a conventional PCR for the clinical management of leishmaniasis. Am J Trop Med Hyg 81 :46–51.
Mary C, Farault F, Droguoul MP, Xeridat B, Scleinitz N, Cuisenier, Dumon H., 2006. Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up. Am J Trop Med Hyg 75 :858–863.
Rioux JA, Lanotte G, Serres E, Pratlong F, Bastien P, Périères J, 1990. Taxonomy of Leishmania: use of isoenzymes and suggestion for a new classification. Ann Parasitol Hum Comp 65 :111–125.
Desjeux P, 2005. Therapeutic options for visceral leishmaniasis. Med Mal Infect 35 :74–76.
Cascio A, Calattini S, Colomba C, Scalmonia C, Galazzi M, Pizzuto M, Camilli R, Gramiccia M, Titone L, Gorbellini M, Antinori S, 2002. Polymerase chain reaction in the diagnosis and prognosis of Mediterranean visceral leishmaniasis in immunocompetent children. Pediatrics 109 :E27.
Cruz I, Chicharro C, Nieto J, Bailo B, Canavate C, Figueras MC, Alvar J, 2006. Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis. J Clin Microbiol 44 :2343–2347.
Gradoni L, Gramiccia M, Pettoello M, Di Martino L, Nocerino A, 1987. A new Leishmania infantum enzymatic variant, agent of visceral leishmaniasis case unresponsive to drugs. Trans R Soc Trop Med Hyg 81 :927–928.
Faraut-Gambarelli F, Piarroux R, Deniau M, Giusiano B, Marty P, Michel G, Faugère B, Dumon H, 1997. In vivo and in vitro resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob Agents Chemother 41 :827–830.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 44 | 44 | 8 |
Full Text Views | 365 | 47 | 0 |
PDF Downloads | 58 | 12 | 0 |
Forty-two patients with visceral leishmaniasis in Tunisia were treated with meglumine antimoniate and followed-up for clinical improvement and blood parasite load determined by quantitative real-time polymerase chain reaction (PCR). Parasite loads before treatment ranged from 27 to 5.3 × 107 parasites/mL. At the end of treatment, parasite load decreased significantly in 39 cured patients (P < 0.001). The decrease in parasite load after treatment was greater than 99% for 34 patients and PCR results became negative in 23 of them. Two patients without clinical improvement showed no or slight decreases in parasite load (209 versus 202 parasites/mL and 1,765 versus 146 parasites/mL). One patient showed had a relapse seven months after showing a good response to treatment. His parasitemia remained high despite a sharp decrease (5.2 × 105 versus 5.9 × 103 parasites/mL).
Abdelmoula MS, M’Hamdi Z, Amri F, Tebib N, Ben Turkia F, Ben Dridi MF, 2003. La leishmaniose viscérale chez l’enfant: facteurs pronostiques. Tunis Med 81 :535–539.
Bouratbine A, Aoun K, Chahed MD, Ben Ismail R, 1998. Données épidémiologiques sur la leishmaniose viscérale infantile en Tunisie en 1993. Med Mal Infect 28 :446–447.
Aoun K, Bouratbine A, 2008. Leishmaniasis. Rakel ER, Bope ET, eds. Conn’s Current Therapy 2008. Philadelphia: Saunders Elsevier, 94–98.
Mary C, Farault F, Lascombe L, Dumon H, 2004. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol 42 :5249–5255.
Antinori S, Calattini S, Piolini R, Longhi E, Bestetti G, Cacsio A, Parravicini C, Gorbellini M, 2009. Is real-time PCR more useful than a conventional PCR for the clinical management of leishmaniasis. Am J Trop Med Hyg 81 :46–51.
Mary C, Farault F, Droguoul MP, Xeridat B, Scleinitz N, Cuisenier, Dumon H., 2006. Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up. Am J Trop Med Hyg 75 :858–863.
Rioux JA, Lanotte G, Serres E, Pratlong F, Bastien P, Périères J, 1990. Taxonomy of Leishmania: use of isoenzymes and suggestion for a new classification. Ann Parasitol Hum Comp 65 :111–125.
Desjeux P, 2005. Therapeutic options for visceral leishmaniasis. Med Mal Infect 35 :74–76.
Cascio A, Calattini S, Colomba C, Scalmonia C, Galazzi M, Pizzuto M, Camilli R, Gramiccia M, Titone L, Gorbellini M, Antinori S, 2002. Polymerase chain reaction in the diagnosis and prognosis of Mediterranean visceral leishmaniasis in immunocompetent children. Pediatrics 109 :E27.
Cruz I, Chicharro C, Nieto J, Bailo B, Canavate C, Figueras MC, Alvar J, 2006. Comparison of new diagnostic tools for management of pediatric Mediterranean visceral leishmaniasis. J Clin Microbiol 44 :2343–2347.
Gradoni L, Gramiccia M, Pettoello M, Di Martino L, Nocerino A, 1987. A new Leishmania infantum enzymatic variant, agent of visceral leishmaniasis case unresponsive to drugs. Trans R Soc Trop Med Hyg 81 :927–928.
Faraut-Gambarelli F, Piarroux R, Deniau M, Giusiano B, Marty P, Michel G, Faugère B, Dumon H, 1997. In vivo and in vitro resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob Agents Chemother 41 :827–830.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 44 | 44 | 8 |
Full Text Views | 365 | 47 | 0 |
PDF Downloads | 58 | 12 | 0 |